Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Government plans £6 billion precision medicine strategy

December 18, 2014 Research and Development, Sales and Marketing ABPI, Cell Therapy Catapult, Ebola, George Osborne, UK, government

The government has committed to a £6 billion investment in scientific research and development as part of its science and …
News

Lundbeck scraps stroke drug

December 18, 2014 Research and Development, Sales and Marketing AIS, DIAS, Lundbeck, acute ischemic stroke, desmoteplase, stroke

Lundbeck has stopped development of its investigational stroke drug desmoteplase following disappointing results from its Phase III studies. The DIAS-3 …
News
Astrazeneca image

AstraZeneca ovarian cancer drug approved in Europe

December 18, 2014 Sales and Marketing AstraZeneca, BRCA, Cambridge, Cancer, FDA, lynparza, olaparib, ovarian

The European Commission has approved AstraZeneca’s Lynparza for the treatment of advanced BRCA-mutated ovarian cancer. Lynparza (olaparib) has been approved …
News
bernard_poussot_roche

Roche adds two to its board

December 18, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernard Poussot, Richard Lift, Roche, Sanofi

Roche intends to grow at its March annual general meeting via the election of Bernard Poussot and Richard Lift who …
Appointment

Roche wins drug discovery award for Gazyvaro

December 18, 2014 Sales and Marketing BPS, British Pharmacological Society, GSK, Gazyvaro, Roche, mekinist

Roche has been named the winner of the 2015 Drug Discover of the Year award by the British Pharmacological Society …
News

PM Society names pharma prize finalists

December 17, 2014 Medical Communications, Sales and Marketing GSK, Mundipharma, Shire, VCCP Health, digital awards, pm society

The finalists for the PM Society Awards have been announced today as pharma and med comms agencies gear up to …
News
Cyramza image

Lilly’s lung cancer drug sees FDA approval

December 17, 2014 Sales and Marketing BMS, Cancer, FDA, NSCLC, cyramza, docetaxel, lilly, opdivo, ramucirumab

Eli Lilly’s lung cancer drug Cyramza (ramucirumab) has been shown the green light by the US Food and Drug Administration …
News
research image

Big pharma spent $112 billion on R&D in 2013

December 17, 2014 Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research

The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …
News
EMA image

Adaptive licensing could ‘transform industry’

December 17, 2014 Research and Development, Sales and Marketing Clinical Pharmacology & Therapeutics, EFPIA, EMA, MHRA, adaptive licesning

Drug regulators should switch to adaptive pathways as the preferred approach to bringing future new medicines to patients, according to …
News
GSK image

GSK Ebola vaccine gets EU support

December 17, 2014 Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …
News
Stevenage Bioscience Catalyst campus image

Cell Therapy Catapult to build £55 million bioscience campus

December 17, 2014 Research and Development, Sales and Marketing Cell Therapy Catapult, UK, bioscience, research, stevenage

UK firm The Cell Therapy Catapult has chosen to build a £55 million state-of-the-art cell therapy manufacturing centre in Stevenage. …
News
Janssen image

Janssen launches HIV combination pill

December 17, 2014 Research and Development, Sales and Marketing BMS, Gilead, HIV, Janssen, NHS, NICE, rezolsta, tybost

Janssen has launched its HIV therapy Rezolsta in the UK, which combines its own Prezista with Gilead’s Tybost. Prezista (darunavir) …
News
philippe_bishop_gilead

Gilead secures senior head from Genentech

December 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Gilead, Philippe Bishop

Dr Philippe Bishop is joining the California-based biopharma firm Gilead from Genentech to be the company’s senior vice president of …
Appointment
Pradaxa image

Boehringer gets NICE nod for Pradaxa

December 16, 2014 Sales and Marketing Boehringer, NHS, NICE, Pradaxa, VTE, dagibatran, ingelheim, warfarin

NICE has confirmed a recommendation for Boehringer Ingelheim’s controversial anti-blood clotting drug Pradaxa, as a treatment for blood clots in …
News
Inlyta image

NICE backs Pfizer’s drug for advanced kidney cancer

December 16, 2014 Sales and Marketing NICE, Pfizer, Sutent, Votrient, Zytiga, axitinib, inlyta, xofigo

UK healthcare guidance body NICE has issued final draft guidance recommending Pfizer’s Inlyta for advanced kidney cancer. The draft recommendation …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026